Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40028748
Localisation
India
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
15/01/2026
Statut
Classification
1.5°C
Année cible
FY2035
Near-Term Targets: STERIL-GENE LIFE SCIENCES PRIVATE LIMITED commits to reduce absolute scope 1 and 2 GHG emissions 100.0% by FY2035 from a FY2024 base year.* STERIL-GENE LIFE SCIENCES PRIVATE LIMITED also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, fuel- and energy-related activities, upstream transportation and distribution, employee commuting and end-of-life treatment of sold products 37.5% within the same timeframe. *The target boundary includes land-related emissions and removals from biogenic feedstocks.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
INE1J5D01011
LEI
335800BJBK3NLFYM4390
Source : Science Based Targets initiative | Données publiques